DNAVSGTBP• 3 Months (Normalized)
DNA vs GTBP (Ginkgo Bioworks Holdings Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Jun 30 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+5.55%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+5.55 pts
DNA outperforming by 5.55 percentage points
DNAGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | DNA Price | DNA Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $10.46 | +5.55% | $- | - | |
| Sep 25, 2026 | $10.66 | +7.57% | $- | - | |
| Sep 24, 2026 | $10.25 | +3.43% | $- | - | |
| Sep 23, 2026 | $8.58 | -13.42% | $7.10 | +1348.98% | -1362.40% |
| Sep 22, 2026 | $9.37 | -5.45% | $- | - | |
| Sep 21, 2026 | $7.98 | -19.48% | $7.18 | +1365.31% | -1384.79% |
| Sep 18, 2026 | $7.88 | -20.48% | $7.16 | +1361.22% | -1381.70% |
| Sep 17, 2026 | $7.84 | -20.89% | $7.49 | +1428.57% | -1449.46% |
| Sep 16, 2026 | $7.06 | -28.76% | $7.81 | +1493.88% | -1522.64% |
| Sep 15, 2026 | $6.99 | -29.47% | $9.00 | +1736.73% | -1766.20% |
| Sep 14, 2026 | $7.01 | -29.26% | $11.63 | +2273.47% | -2302.73% |
| Sep 11, 2026 | $6.75 | -31.89% | $8.61 | +1657.14% | -1689.03% |
| Sep 10, 2026 | $6.78 | -31.58% | $6.18 | +1161.22% | -1192.80% |
| Sep 09, 2026 | $6.79 | -31.48% | $5.98 | +1120.41% | -1151.89% |
| Sep 08, 2026 | $6.94 | -29.97% | $- | - |
Page 1 of 5